Sleeve lobectomy for non-small cell lung cancer and carcinoids: Results in 160 cases

A. Terzi, A. Lonardoni, G. Falezza, G. Furlan, P. Scanagatta, F. Pasini, F. Calabrò

Research output: Contribution to journalArticlepeer-review


Objective: To assess operative mortality (OM), morbidity and long-term results of sleeve lobectomies performed for non-small cell lung cancer (NSCLC) and carcinoids during a 35-year period. Methods: A retrospective review of patients who underwent a sleeve lobectomy for NSCLC and carcinoids was undertaken, univariate and multivariate analyses of factors influencing early mortality in NSCLC were performed and for this purpose the series was split into an early and a contemporary phase, the Kaplan-Meier method was used to calculate the cumulative survival rate, and statistical significance was calculated with the log-rank test. Causes of death were evaluated in relation to the stage of the disease. Results: OM for NSCLC was 14.6% in the early phase and 6% in the contemporary one; late stenosis occurred in 7.7% of NSCLC patients in the early phase and in 2% in the contemporary one. No OM or late stenosis occurred in carcinoid patients. Three, 5 and 10-year survival rates excluding carcinoids were 77, 62 and 31% for stage I(A-B), 45, 34 and 27% for stage II(A-B), 33, 22 and 0% for stage III(A-B). The 10-year survival rate for carcinoids was 100%. There was no significant difference in long-term survival between stages II and III, while the difference between stage I and stages II and III was significant (P

Original languageEnglish
Pages (from-to)888-893
Number of pages6
JournalEuropean Journal of Cardio-thoracic Surgery
Issue number5
Publication statusPublished - 2002


  • Lung cancer
  • Sleeve lobectomy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery


Dive into the research topics of 'Sleeve lobectomy for non-small cell lung cancer and carcinoids: Results in 160 cases'. Together they form a unique fingerprint.

Cite this